The Cost Saving Potential of Utilizing Biosimilar Medicines in Biologic Naive Severe Rheumatoid Arthritis Patients von Whitehouse, J, Walsh, K, Papandrikopoulou, A, Hoad, R

Volltext

AB1403 Comprehensive target-directed approach for the development of a highly-comparable rituximab biosimilar von da Silva, A., Grau, R., Stangler, T., Summer, H., Meyer, I., Rohde, A., Papandrikopoulou, A., Visser, J.M.

Volltext

PRO69 Real-World Treatments and Health-Related Quality of Life in Patients with Prurigo Nodularis in the Lotus PN Observational Trial von Stander, S., Lim-Watson, M., Berger, T., Silverberg, J., Weisshaar, E., Friedman, A., Szepietowski, J.C., Kim, B., Pariser, D., Ekanayake-Bohlig, S., Metz, M., Papandrikopoulou, A., Jiang, G.L., Paolini, J., Martin, D., Yosipovitch, G.

Volltext

PMS104 - The Cost Saving Potential of Utilizing Biosimilar Medicines in Biologic Naive Severe Rheumatoid Arthritis Patients von Whitehouse, J., Walsh, K., Papandrikopoulou, A., Hoad, R.

Volltext

Embryonic MAP2 lacks the cross-linking sidearm sequences and dendritic targeting signal of adult MAP2 von Papandrikopoulou, Anastasia, Doll, Thierry, Tucker, Richard P, Garner, Craig C, Matus, Andrew

Volltext

Nucleotide and amino acid sequences of embryonic rat MAP2c von DOLL, T, PAPADRIKOPOULOU, A, MATUS, A

Volltext

Cloning and expression of γ‐glutamyl transpeptidase from isolated porcine brain capillaries von PAPANDRIKOPOULOU, Anastasia, FREY, Andreas, GASSEN, Hans G.

Volltext

Synthesis of Apolipoprotein A‐1 in Pig Brain Microvascular Endothelial Cells von Weiler‐Güttler, Hartmut, Sommerfeldt, Michaela, Papandrikopoulou, Anastasia, Mischek, Uwe, Bonitz, Dorothea, Frey, Andreas, Grupe, Matthias, Scheerer, Joachim, Gassen, Hans G.

Volltext

Embryonic MAP2 lacks the cross-linking side arm sequences and dendritic targeting signal of adult MAP2 von PAPANDRIKOPOULOU, A, DOLL, T, TUCKER, R. P, GARNER, C. C, MATUS, A

Volltext

Target-Directed Development of a Proposed Biosimilar Rituximab (GP2013): Comparability of Antibody-Dependent Cellular Cytotoxicity Activity and Pre-Clinical Pharmacokinetics and Ph... von da Silva, Antonio, Kronthaler, Ulrich, Meyer, Ines, Papandrikopoulou, Anastassia, Stangler, Thomas, Visser, Jan Marinus

Volltext

PG111 A COST-EFFICACY ANALYSIS MODEL FOR PHYSICIAN ADMINISTERED ANTI-TUMOR NECROSIS FACTOR AGENTS IN CROHN'S DISEASE von Waters, H, McKenzie, RS, Tang, B, Piech, CT, Papandrikopoulou, N

Volltext

PG117 REALWORLD DOSING OF ANTI-TUMOR NECROSIS FACTOR THERAPIES IN THE TREATMENT OF ADULTS WITH CROHN'S DISEASE von Waters, H, Meekins, T, Bewtra, A, McKenzie, RS, Tang, B, Piech, CT, Papandrikopoulou, N

Volltext